Volume 19 - Issue 12 - December 2006

Editor's Perspective »

The FDA: Where Do We Go From Here?

By Jeff Hall, Executive Editor | 1521 reads | 0 comments

    How bad have things gotten at the Food and Drug Administration (FDA)? When you consider some of the recent reports and developments over the past few months, it is clear that the FDA has significant credibility issues.

    In June, a report by U.S. Rep. Henry A. Waxman revealed some eye-opening trends in FDA enforcement actions in recent years. According to the report, which reportedly involved an investigation and review of copious internal agency enforcement documentation, there was a greater than 50 percent decrease from 2000 to 2005 in the number of FDA



Diabetes Watch »

How To Achieve Optimal Perioperative Glycemic Control In Patients With Diabetes

By Emily A. Cook, DPM, Jeremy J. Cook, DPM, and Barry I. Rosenblum, DPM | 14890 reads | 0 comments

    As the role of the podiatric service becomes more integral to a multidisciplinary approach to diabetic limb salvage at an increasing number of institutions nationwide, many podiatric surgeons find themselves admitting these patients to their own service. The surgical and anesthesia teams often execute perioperative assessment and preparation, especially in non-elective procedures.

    This article serves as a primer in glucose management for podiatric surgeons working in this capacity and in no way supersedes the utility of a medical consult when indicated



Practice Builders »

Secrets To Obtaining 100 Percent Patient Satisfaction

By Kristin Titko, DPM | 6665 reads | 0 comments

    Do we all know the basics of how to make our patients’ visits satisfactory when they are in our office? What brings your patients back to your office once they have been there? What encourages your patients to send their friends, family and acquaintances to your practice? In today’s world of decreasing reimbursements for our hard work, we need to know how to work smarter so it does not feel like we are forced to work harder. Retaining patients and increasing the number of new patients we see can be easier than you think. All it requires is a little extra time and effort.



Sports Medicine »

Bike Fit Evaluation: Can It Help Diagnose And Prevent Cycling Injuries?

By Richard T. Bouché, DPM, Peter M. Vincent, DPM, and Katrina Sullivan, DPM | 14354 reads | 0 comments

    The sport of cycling has seen tremendous growth in the past decade. Athletes are utilizing bicycling not only as their primary sport but also as a form of cross training and rehabilitation. As a result of this growth, there has been a corresponding increase in the incidence of non-traumatic (overuse) injuries. Wilber, et. al., found 85 percent of cyclists to be suffering with one or more overuse injuries with the following distribution: neck (48.8 percent), knee (41.7 percent), groin and buttocks (36.1 percent), hand (31.1 percent) and back (30.3 percent).1

&



Feature »

Emerging Concepts In Podiatric Biomechanics

By Kevin A. Kirby, DPM, MS | 51532 reads | 0 comments

    The world of podiatric biomechanics is very different now than when Merton Root, DPM, created the first Department of Podiatric Biomechanics at the California College of Chiropody in San Francisco in 1966.1 During those exciting early years of development within the new subspecialty of “podiatric biomechanics,” Dr. Root and his podiatric colleagues created a classification system, based on the subtalar joint (STJ) neutral position, that remains to this day the most complete method by which to classify the structure of the foot and lower extremity.1,2



Feature »

A Closer Look At Bone Stimulators For Charcot

By Michael S. Downey, DPM, FACFAS | 29610 reads | 0 comments

     Charcot osteoarthropathy remains a chronic, progressive and destructive process that often affects the bony architecture and joints of the foot and ankle, primarily in patients with diabetic peripheral neuropathy. Despite advances in the diagnosis and management of this condition, the deformity continues to be associated with a high incidence of recurrence, treatment failure and resultant morbidity. If left untreated, Charcot foot predictably leads to deformity, ulceration, infection and amputation.

     The mainstays of treatment for the Charcot foot hav